As shown in Table 2, miR-425-5p was identified to potentially target the GFAP gene, which is expressed as a marker of differentiated GBM cells, so that downregulation of miR-425-5p in GSCs could increase GFAP levels in the course of differentiation into GBM cells. The gene discussed is GFAP; the disease is glioblastoma.